Literature DB >> 3136031

Non-A, non-B hepatitis; factors involved in progression to chronicity.

A Biglino1, M Depaoli, G Cariti, D Giacobbi, P Gioannini.   

Abstract

A cross-sectional, longitudinal study was undertaken on a group of acute non-A, non-B hepatitis patients, as well as on a control group of hepatitis B patients, in order to assess both the prevalence of the most important factors favoring infection, and the relevance of these factors in promoting evolution towards chronic liver disease. Exposures to unknown risk factors were present in 47.4% of acute non-A, non-B infections, followed by blood transfusions (17.9%), sporadic exposures (17.9%) and drug addiction (16.6%). Unknown as well as sporadic exposures showed a greater prevalence in control population if compared to non-A, non-B cases, while drug addiction was equally represented in the two groups, and blood transfusion nearly absent from control group. The risk of evolution to chronic liver disease was about 13 times greater in non-A, non-B group than in controls, with the greatest risk for drug addicts and the lowest for patients with unknown exposures. Among patients with known exposures, the lowest risk of chronic hepatitis was observed in post-transfusion and in sporadic cases, while the greatest was observed in drug addicts.

Entities:  

Mesh:

Year:  1988        PMID: 3136031     DOI: 10.1007/bf00144761

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  15 in total

1.  Non-A, non-B hepatitis.

Authors:  S M Feinstone; R H Purcell
Journal:  JAMA       Date:  1978-09-22       Impact factor: 56.272

Review 2.  The current status of non-A, non-B viral hepatitis.

Authors:  J Shorey
Journal:  Am J Med Sci       Date:  1985-06       Impact factor: 2.378

3.  Acute non-A, non-B hepatitis--clinical, epidemiological and histological characteristics.

Authors:  P Kryger; J Aldershvile; P Christoffersen; F Hardt; E Juhl; L R Mathiesen; J O Nielsen; H Poulsen
Journal:  Scand J Infect Dis       Date:  1980

Review 4.  Post-transfusion hepatitis: current perspectives.

Authors:  R D Aach; R A Kahn
Journal:  Ann Intern Med       Date:  1980-04       Impact factor: 25.391

5.  Non-B hepatitis in Japanese recipients of blood transfusions: clinical and serologic studies after the introduction of laboratory screening of donor blood for hepatitis B surface antigen.

Authors:  A Tateda; K Kikuchi; Y Numazaki; R Shirachi; N Ishida
Journal:  J Infect Dis       Date:  1979-05       Impact factor: 5.226

6.  Epidemiology of sporadic acute non-A, non-B hepatitis in Japan: a comparison with hepatitis A and B.

Authors:  A Nagata; K Kiyosawa; Y Koike; M Miura; Y Gibo; T Sodeyama; S Wada; Y Akahane; S Furuta
Journal:  Am J Gastroenterol       Date:  1985-04       Impact factor: 10.864

7.  Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology.

Authors:  D C Wong; R H Purcell; M A Sreenivasan; S R Prasad; K M Pavri
Journal:  Lancet       Date:  1980-10-25       Impact factor: 79.321

8.  Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis.

Authors:  G Realdi; A Alberti; M Rugge; A M Rigoli; F Tremolada; L Schivazappa; A Ruol
Journal:  Gut       Date:  1982-04       Impact factor: 23.059

9.  Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population.

Authors:  M J Alter; R J Gerety; L A Smallwood; R E Sampliner; E Tabor; F Deinhardt; G Frösner; G M Matanoski
Journal:  J Infect Dis       Date:  1982-06       Impact factor: 5.226

10.  Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type.

Authors:  M S Khuroo
Journal:  Am J Med       Date:  1980-06       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.